Search

everythinglearnresearchcommunity

for

Search:↓

Macrophage activation syndrome can be a deadly first sign of systemic lupus erythematosus.

Experts recommend starting systemic treatment for alopecia areata when the condition is severe or causes significant distress.

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

Prednisone reduces organ mast cell infiltration but does not alter the abnormal appearance of mast cells in systemic mastocytosis.

COVID-19 may trigger systemic lupus erythematosus, requiring careful diagnosis and treatment.

Rituximab effectively managed a difficult case of juvenile lupus with complications, reducing the need for steroids.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

Ovalbumin–aluminum sensitization causes increased pain sensitivity and nerve changes in mice.

Jieduquyuziyin prescription helps treat SLE with atherosclerosis by improving cholesterol removal and reducing inflammation.

Mitochondrial Complex I reduces inflammation and increases bone breakdown by affecting certain immune cells.

Oxidative stress plays a significant role in vitiligo, and both skin and non-skin cells may be involved.

Surfactants in spanlastics improve drug delivery by making nanovesicles more flexible and stable for painless administration through the mouth.

Women with pattern hair loss may have more stress in their bodies due to a lack of NRF2, a protein. Eating healthy and losing weight could help reduce this stress and improve hair loss. NRF2 boosters might also help treat this type of hair loss.

The document concludes that understanding hair and feather regeneration can help develop new regenerative medicine strategies.

NDP-MSH protects brain cells and reduces inflammation in Parkinson's disease by activating MC1R and involving Tregs.

MLPH helps hair grow by activating IGF-1 signaling in hair cells.

Sonidegib effectively treated basal cell carcinoma in a patient with lupus without worsening lupus symptoms.

Wnt-activating drugs generally do not increase cancer risk.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Blocking the NOTCH pathway can prevent fibrosis in systemic sclerosis.

Recombinant Human Annexin A5 may help treat localized scleroderma by reducing skin thickening and inflammation.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

Certain KIR genes in Indian SLE patients are linked to disease severity and could be biomarkers.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

Topical metformin helped regrow hair in two women with a hard-to-treat scarring hair loss condition.

Some COVID-19 patients have different skin problems, which might be the only sign of the virus or related to other health issues.

Adult female acne is complex and requires a combination of treatments for effective management.